{
  "case_id": "case_0003",
  "provider": "goog",
  "status": "processed",
  "patient_demographics": {
    "age": 41.24,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- left optic nerve (cranial nerve II) and right medulla.\n  \nRemaining signs are better explained by:\n- left midbrain lesion\n\nThan the suggested:\n- left pontine tegmentum, right cerebellar hemisphere, left cerebral hemisphere white matter, left medulla and bilateral cervical spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "left midbrain",
          "right medulla",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Optic Nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Pontine Tegmentum",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Cerebellar Hemisphere",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "Cerebral Hemisphere White Matter",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Medulla",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "Medulla",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Cervical Spinal Cord",
            "side": "bilateral",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)",
          "right medulla"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [
          "left midbrain"
        ],
        "additional_lesions_in_ft": [
          "left Pontine Tegmentum",
          "right Cerebellar Hemisphere",
          "left Cerebral Hemisphere White Matter",
          "left Medulla",
          "bilateral Cervical Spinal Cord"
        ]
      },
      "scoring": {
        "gt_lesion_count": 3,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 1,
        "additional_lesion_count": 5,
        "proportion_correct": 0.6666666666666666,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.3333333333333333,
        "proportion_additional": 1.6666666666666667
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Neuromyelitis Optica Spectrum Disorder; Myelin Oligodendrocyte Glycoprotein Antibody Disease; Neurosarcoidosis",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple Sclerosis",
          "Neuromyelitis Optica Spectrum Disorder",
          "Myelin Oligodendrocyte Glycoprotein Antibody Disease",
          "Neurosarcoidosis"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Pelvic organ prolapse": "comorbidity",
          "Solar keratosis": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Pelvic organ prolapse",
          "Solar keratosis"
        ],
        "additional_diagnoses": [
          "Neuromyelitis Optica Spectrum Disorder",
          "Myelin Oligodendrocyte Glycoprotein Antibody Disease",
          "Neurosarcoidosis"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with MRI including the Brain and CSF test for Oligoclonal Bands - would potetially inform a diagnosis/details of multiple sclerosis.\n\n- But incomplete, should also include: MRI Orbits.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and entire spinal cord with and without gadolinium contrast",
          "Lumbar Puncture for CSF analysis",
          "CSF Oligoclonal Bands and IgG Index",
          "Serum Aquaporin-4 Antibody",
          "Serum Myelin Oligodendrocyte Glycoprotein Antibody",
          "Visual Evoked Potentials",
          "Serum for paired Oligoclonal Band analysis",
          "Full Blood Count",
          "Urea and Electrolytes",
          "Liver Function Tests",
          "Antinuclear Antibody",
          "Angiotensin Converting Enzyme",
          "Syphilis Serology",
          "Vitamin B12 level",
          "CT of the chest"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ]
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 2,
        "missing_tests_count": 1,
        "proportion_found": 0.6666666666666666,
        "proportion_missing": 0.3333333333333333
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-Dose Intravenous Corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "To reduce the severity and duration of the acute, disabling neurological relapse.",
              "To hasten functional recovery by suppressing acute CNS inflammation."
            ]
          },
          {
            "treatment": "High-Efficacy Disease-Modifying Therapy",
            "timing": "Delay",
            "reasons": [
              "A definitive diagnosis must be confirmed and key mimics (e.g., NMOSD, MOGAD) must be excluded, as some DMTs can worsen these conditions.",
              "Requires time for necessary pre-treatment safety screening and comprehensive patient counselling."
            ]
          },
          {
            "treatment": "Multidisciplinary Team Rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "To maximize functional recovery from current deficits including gait instability, weakness, and ataxia.",
              "To improve patient safety, prevent falls, and address functional independence early in the disease course."
            ]
          },
          {
            "treatment": "Symptomatic Management for Spasticity",
            "timing": "Start Now",
            "reasons": [
              "To provide relief from painful spasticity.",
              "To improve mobility and facilitate more effective engagement in physical therapy."
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-Dose Intravenous Corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "To reduce the severity and duration of the acute, disabling neurological relapse.",
              "To hasten functional recovery by suppressing acute CNS inflammation."
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +)."
              ]
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "High-Efficacy Disease-Modifying Therapy",
            "timing": "Delay",
            "reasons": [
              "A definitive diagnosis must be confirmed and key mimics (e.g., NMOSD, MOGAD) must be excluded, as some DMTs can worsen these conditions.",
              "Requires time for necessary pre-treatment safety screening and comprehensive patient counselling."
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +)."
              ]
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 3,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.3333333333333333,
          "proportion_reasons_missed": 0.6666666666666666
        }
      }
    }
  }
}